Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug-Resistant Tuberculosis”

135 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 135 results

Large-scale testing (Phase 3)Study completedNCT04062201
What this trial is testing

Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care

Who this might be right for
TuberculosisPre-XDR-TBExtensively Drug-Resistant Tuberculosis+2 more
Wits Health Consortium (Pty) Ltd 402
Not applicableStudy completedNCT04208789
What this trial is testing

Artificial Inteligent for Diagnosing Drug-Resistant Tuberculosis

Who this might be right for
MDR TuberculosisResistance to Tuberculostatic Drugs
Hasanuddin University 524
Not applicableLooking for participantsNCT01212003
What this trial is testing

Training Protocol on the Natural History of Tuberculosis

Who this might be right for
Mycobacterium InfectionsTuberculosis, Multidrug-ResistantLatent Tuberculosis+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 150
Not applicableStudy completedNCT04239326
What this trial is testing

Clinical Evaluation of tNGS for Diagnosis of DR-TB

Who this might be right for
Tuberculosis, Multidrug-Resistant
Foundation for Innovative New Diagnostics, Switzerland 800
Not applicableNot Yet RecruitingNCT07017803
What this trial is testing

Molecular Epidemiology, Strains Genotyping of Multi-drug Resistant Tuberculosis Circulating in Central Africa Region

Who this might be right for
Tuberculosis, Multi Drug ResistantStrainsMolecular Epidemiology+2 more
Centre de Recherche Médicale de Lambaréné 460
Not applicableStudy completedNCT06671808
What this trial is testing

HIV and Multi-Drug Resistant Tuberculosis: a Study on Clinical Outcomes

Who this might be right for
HIV InfectionMDR-TB
Zahedan University of Medical Sciences 222,128
Not applicableApproved For MarketingNCT01464762
What this trial is testing

Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA
Large-scale testing (Phase 3)WithdrawnNCT01600963
What this trial is testing

Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis

Who this might be right for
Multi-drug Resistant Tuberculosis
Janssen Infectious Diseases BVBA
Not applicableNot Yet RecruitingNCT06674291
What this trial is testing

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Who this might be right for
Tuberculosis, Multidrug-Resistant
Korea Otsuka Pharmaceutical Co., Ltd. 222
Large-scale testing (Phase 3)Not Yet RecruitingNCT07268664
What this trial is testing

Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese Cohort

Who this might be right for
Rifampicin Resistant TuberculosisPulmonary TuberculosisTuberculosis+1 more
Beijing Chest Hospital 120
Not applicableStudy completedNCT03057756
What this trial is testing

Treatment of Tuberculosis Multidrug Resistance Treatment of Tuberculosis Multidrug Resistance

Who this might be right for
Multi-drug Resistant Tuberculosis
Centre de Recherche Médicale de Lambaréné 23
Large-scale testing (Phase 3)Study completedNCT02454205
What this trial is testing

An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis

Who this might be right for
TuberculosisMultidrug Resistant TuberculosisExtensively-drug Resistant Tuberculosis
University of Cape Town 154
Post-approval studies (Phase 4)Study completedNCT01521364
What this trial is testing

Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients

Who this might be right for
Multidrug-resistant TuberculosisExtensively Drug-resistant Tuberculosis
University Medical Center Groningen 7
Not applicableActive Not RecruitingNCT04567368
What this trial is testing

TB-CAPT MTB/XDR Study

Who this might be right for
TuberculosisResistance BacterialDiagnoses Disease
Foundation for Innovative New Diagnostics, Switzerland 753
Testing effectiveness (Phase 2)Study completedNCT01222338
What this trial is testing

Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients

Who this might be right for
Tuberculosis
Lisichansk Regional Tuberculosis Dispensary 123
Not applicableLooking for participantsNCT06590428
What this trial is testing

Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis

Who this might be right for
Rifampin-resistant TuberculosisDrug-resistant Tuberculosis
Albert Einstein College of Medicine 280
Not applicableNot Yet RecruitingNCT07126639
What this trial is testing

A Study on the Short-course Treatment Regimen Containing Pretomanid for Drug-resistant Tuberculosis

Who this might be right for
Efficacy and Safety
Wuhan Pulmonary Hospital 200
Large-scale testing (Phase 3)UnknownNCT04081077
What this trial is testing

PRACTECAL-PKPD Sub Study

Who this might be right for
Multi-drug Resistant TuberculosisExtensively Drug-Resistant TuberculosisPulmonary Tuberculosis
Medecins Sans Frontieres, Netherlands 240
Testing effectiveness (Phase 2)Study completedNCT00727844
What this trial is testing

Linezolid to Treat Extensively-Drug Resistant Tuberculosis

Who this might be right for
Pulmonary TuberculosisMultidrug Resistant TuberculosisExtensively Drug Resistant Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 41
Not applicableLooking for participantsNCT05022238
What this trial is testing

Hotspots, Households and Hospitals: Enhanced Drug-resistant Tuberculosis Case Finding in Namibia

Who this might be right for
Tuberculosis, Multidrug-Resistant
University of Namibia 2,100
Next Page